directSTIM™ DBS System
Neurological Disorders (e.g., Parkinson's Disease, Essential Tremor)
Key Facts
About Aleva Neurotherapeutics
Aleva Neurotherapeutics is a Swiss innovator and commercial-stage company in the neuromodulation space, specializing in high-precision Directional Deep Brain Stimulation (DBS). The company's core technology combines a directional lead with 24 contacts and a Multiple Independent Current Control (MICC) generator, designed to provide superior targeting of brain structures to widen the therapeutic window and reduce side effects. Having achieved CE mark for its directSTIM™ system, Aleva is now focused on commercial rollout in Europe via partnerships with leading neurological clinics, backed by a strong IP portfolio of over 90 granted patents. The company leverages Swiss precision manufacturing and is actively expanding its team to support growth and further technological development.
View full company profile